{"count": 7, "results": [{"_id": "40895950", "pmid": 40895950, "title": "An Island Rash: A Case Study of Exercise-Induced Vasculitis.", "journal": "Cureus", "authors": ["Ferreira Veloso M Sr", "Alves da Silva C", "Ferreira Vieira J"], "date": "2025-07-28T00:00:00Z", "doi": "10.7759/cureus.88909", "meta_date_publication": "2025 Jul", "meta_volume": "17", "meta_issue": "7", "meta_pages": "e88909", "score": 50257.477, "text_hl": "A 65-year-old female teacher with @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@, @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@, and @DISEASE_Dyslipidemias @DISEASE_MESH:D050171 @@@dyslipidemia@@@ contacted her family physician via email regarding a one-day history of a bilateral lower limb @<m>DISEASE_Exanthema</m> @DISEASE_MESH:D005076 @@@rash@@@. Her medications included @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@. ", "citations": {"NLM": "Ferreira Veloso M Sr, Alves da Silva C, Ferreira Vieira J. An Island Rash: A Case Study of Exercise-Induced Vasculitis. Cureus. 2025 Jul;17(7):e88909. PMID: 40895950", "BibTeX": "@article{40895950, title={An Island Rash: A Case Study of Exercise-Induced Vasculitis.}, author={Ferreira Veloso M Sr and Alves da Silva C and Ferreira Vieira J}, journal={Cureus}, volume={17}, number={7}, pages={e88909}}"}}, {"_id": "35220243", "pmid": 35220243, "title": "Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?", "journal": "Anticancer Res", "authors": ["Ciccarese C", "Iacovelli R", "Buti S", "Primi F", "Astore S", "Massari F", "Ferrara MG", "Palermo G", "Foschi N", "Iacovelli V", "Rossi E", "Schinzari G", "Bove P", "Bassi P", "Bria E", "Tortora G"], "date": "2022-03-01T00:00:00Z", "doi": "10.21873/anticanres.15620", "meta_date_publication": "2022 Mar", "meta_volume": "42", "meta_issue": "3", "meta_pages": "1487-1493", "score": 50247.0, "text_hl": "The concomitant use of @CHEMICAL_Nivolumab @CHEMICAL_MESH:D000077594 @@@nivolumab@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was well tolerated; adverse events (AEs) of any grade occurred in 75% of @SPECIES_9606 @@@patients@@@ (mainly @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@, @DISEASE_Pruritus @DISEASE_MESH:D011537 @@@pruritus@@@, @<m>DISEASE_Exanthema</m> @DISEASE_MESH:D005076 @@@rash@@@, and @DISEASE_Asthenia @DISEASE_MESH:D001247 @@@asthenia@@@). ", "citations": {"NLM": "Ciccarese C, Iacovelli R, Buti S, Primi F, Astore S, Massari F, Ferrara MG, Palermo G, Foschi N, Iacovelli V, Rossi E, Schinzari G, Bove P, Bassi P, Bria E, Tortora G. Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active? Anticancer Res. 2022 Mar;42(3):1487-1493. PMID: 35220243", "BibTeX": "@article{35220243, title={Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?}, author={Ciccarese C and Iacovelli R and Buti S and Primi F and Astore S and Massari F and Ferrara MG and Palermo G and Foschi N and Iacovelli V and Rossi E and Schinzari G and Bove P and Bassi P and Bria E and Tortora G}, journal={Anticancer Res}, volume={42}, number={3}, pages={1487-1493}}"}}, {"_id": "32416251", "pmid": 32416251, "title": "Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer.", "journal": "Ann Oncol", "authors": ["Rugo HS", "André F", "Yamashita T", "Cerda H", "Toledano I", "Stemmer SM", "Jurado JC", "Juric D", "Mayer I", "Ciruelos EM", "Iwata H", "Conte P", "Campone M", "Wilke C", "Mills D", "Lteif A", "Miller M", "Gaudenzi F", "Loibl S"], "date": "2020-08-01T00:00:00Z", "doi": "10.1016/j.annonc.2020.05.001", "meta_date_publication": "2020 Aug", "meta_volume": "31", "meta_issue": "8", "meta_pages": "1001-1010", "score": 50237.61, "text_hl": "Preventive anti-@<m>DISEASE_Exanthema</m> @DISEASE_MESH:D005076 @@@rash@@@ medication resulted in lower incidence (any grade, 26.7% versus 64.1%) and severity of @<m>DISEASE_Exanthema</m> @DISEASE_MESH:D005076 @@@rash@@@ (grade 3, 11.6% versus 22.7%) versus no preventative medication. ", "citations": {"NLM": "Rugo HS, André F, Yamashita T, Cerda H, Toledano I, Stemmer SM, Jurado JC, Juric D, Mayer I, Ciruelos EM, Iwata H, Conte P, Campone M, Wilke C, Mills D, Lteif A, Miller M, Gaudenzi F, Loibl S. Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer. Ann Oncol. 2020 Aug;31(8):1001-1010. PMID: 32416251", "BibTeX": "@article{32416251, title={Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer.}, author={Rugo HS and André F and Yamashita T and Cerda H and Toledano I and Stemmer SM and Jurado JC and Juric D and Mayer I and Ciruelos EM and Iwata H and Conte P and Campone M and Wilke C and Mills D and Lteif A and Miller M and Gaudenzi F and Loibl S}, journal={Ann Oncol}, volume={31}, number={8}, pages={1001-1010}}"}}, {"_id": "33164331", "pmid": 33164331, "title": "Resolution of confluent and reticulated papillomatosis after bariatric surgery.", "journal": "Clin Obes", "authors": ["Krishnamoorthy M", "Nadler E", "Vaidya S"], "date": "2021-02-01T00:00:00Z", "doi": "10.1111/cob.12427", "meta_date_publication": "2021 Feb", "meta_volume": "11", "meta_issue": "1", "meta_pages": "e12427", "score": 50237.055, "text_hl": "@DISEASE_Glycogen_Storage_Disease_Type_VI @DISEASE_MESH:D006013 @@@Her@@@ @DISEASE_Skin_Diseases @DISEASE_MESH:D012871 @@@dermatosis@@@ proved recalcitrant to antibiotics and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ but started to resolve immediately after bariatric surgery. ", "citations": {"NLM": "Krishnamoorthy M, Nadler E, Vaidya S. Resolution of confluent and reticulated papillomatosis after bariatric surgery. Clin Obes. 2021 Feb;11(1):e12427. PMID: 33164331", "BibTeX": "@article{33164331, title={Resolution of confluent and reticulated papillomatosis after bariatric surgery.}, author={Krishnamoorthy M and Nadler E and Vaidya S}, journal={Clin Obes}, volume={11}, number={1}, pages={e12427}}"}}, {"_id": "24507578", "pmid": 24507578, "pmcid": "PMC3923099", "title": "Rosacea-like facial rash related to metformin administration in a young woman", "journal": "BMC Pharmacol Toxicol", "authors": ["Mumoli L", "Gambardella A", "Labate A", "Succurro E", "De Sarro G", "Arturi F", "Gallelli L"], "date": "2014-02-08T00:00:00Z", "doi": "10.1186/2050-6511-15-3", "meta_date_publication": "2014 Feb 8", "meta_volume": "15", "meta_issue": "", "meta_pages": "3", "score": 50076.51, "text_hl": "...@<m>DISEASE_Exanthema</m> @DISEASE_MESH:D005076 @@@Skin rash@@@ during @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment.", "citations": {"NLM": "Mumoli L, Gambardella A, Labate A, Succurro E, De Sarro G, Arturi F, Gallelli L. Rosacea-like facial rash related to metformin administration in a young woman BMC Pharmacol Toxicol. 2014 Feb 8;15():3. PMID: 24507578", "BibTeX": "@article{24507578, title={Rosacea-like facial rash related to metformin administration in a young woman}, author={Mumoli L and Gambardella A and Labate A and Succurro E and De Sarro G and Arturi F and Gallelli L}, journal={BMC Pharmacol Toxicol}, volume={15}, pages={3}}"}}, {"_id": "16882868", "pmid": 16882868, "title": "Rare case of metformin-induced leukocytoclastic vasculitis.", "journal": "Ann Pharmacother", "authors": ["Ben Salem C", "Hmouda H", "Slim R", "Denguezli M", "Belajouza C", "Bouraoui K"], "date": "2006-09-01T00:00:00Z", "doi": "10.1345/aph.1H155", "meta_date_publication": "2006 Sep", "meta_volume": "40", "meta_issue": "9", "meta_pages": "1685-7", "score": 50062.63, "text_hl": "Our @SPECIES_9606 @@@patient@@@ developed a @<m>DISEASE_Exanthema</m> @DISEASE_MESH:D005076 @@@rash@@@ within a few days of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ administration. ", "citations": {"NLM": "Ben Salem C, Hmouda H, Slim R, Denguezli M, Belajouza C, Bouraoui K. Rare case of metformin-induced leukocytoclastic vasculitis. Ann Pharmacother. 2006 Sep;40(9):1685-7. PMID: 16882868", "BibTeX": "@article{16882868, title={Rare case of metformin-induced leukocytoclastic vasculitis.}, author={Ben Salem C and Hmouda H and Slim R and Denguezli M and Belajouza C and Bouraoui K}, journal={Ann Pharmacother}, volume={40}, number={9}, pages={1685-7}}"}}, {"_id": "27574928", "pmid": 27574928, "title": "DRESS Syndrome Following Metformin Administration: A Case Report and Review of the Literature.", "journal": "Am J Ther", "authors": ["Voore P", "Odigwe C", "Mirrakhimov AE", "Rifai D", "Iroegbu NA"], "date": "2016-11-01T00:00:00Z", "doi": "10.1097/MJT.0000000000000292", "meta_date_publication": "2016 Nov/Dec", "meta_volume": "23", "meta_issue": "6", "meta_pages": "e1970-e1973", "score": 50060.848, "text_hl": "We report a case of this syndrome in a 40-year-old man presenting with a @<m>DISEASE_Exanthema</m> @DISEASE_MESH:D005076 @@@rash@@@, generalized @DISEASE_Pruritus @DISEASE_MESH:D011537 @@@pruritus@@@, @DISEASE_Lymphatic_Diseases @DISEASE_MESH:D008206 @@@lymphadenopathy@@@, and @DISEASE_Eosinophilia @DISEASE_MESH:D004802 @@@eosinophilia@@@ after @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment. ", "citations": {"NLM": "Voore P, Odigwe C, Mirrakhimov AE, Rifai D, Iroegbu NA. DRESS Syndrome Following Metformin Administration: A Case Report and Review of the Literature. Am J Ther. 2016 Nov/Dec;23(6):e1970-e1973. PMID: 27574928", "BibTeX": "@article{27574928, title={DRESS Syndrome Following Metformin Administration: A Case Report and Review of the Literature.}, author={Voore P and Odigwe C and Mirrakhimov AE and Rifai D and Iroegbu NA}, journal={Am J Ther}, volume={23}, number={6}, pages={e1970-e1973}}"}}]}